This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Nancy Levin: Innovator in Obesity Treatment
Introduction
Nancy Levin is a prominent inventor based in Newbury Park, California. She has made significant contributions to the field of obesity treatment through her innovative research and development. Her work focuses on the development of long-half derivatives of the obesity protein OB, which has the potential to revolutionize how obesity is treated.
Latest Patents
Nancy Levin holds 1 patent for her invention titled "OB protein-polymer chimeras." This invention specifically concerns OB protein-immunoglobulin chimeras and polyethylene glycol (PEG)-OB derivatives, which exhibit an extended half-life compared to the corresponding native OB proteins. The invention also relates to methods for treating obesity by utilizing these long half-life derivatives of OB.
Career Highlights
Nancy Levin is associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. Her work at Genentech has been instrumental in advancing the understanding and treatment of obesity.
Collaborations
Throughout her career, Nancy has collaborated with notable colleagues, including Frederic DeSauvage and Richard L Vandlen. These collaborations have further enhanced her research and contributed to the success of her inventions.
Conclusion
Nancy Levin's innovative work in the field of obesity treatment exemplifies the impact of scientific research on public health. Her contributions continue to pave the way for new therapeutic approaches to combat obesity.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile